SOCS-1 Promoter Methylation and Treatment Response in Chronic Hepatitis C Patients Receiving Pegylated-Interferon/Ribavirin

[1] Hoofnagle JH(2002)Course and outcome of hepatitis C Hepatology 36 S21-9

[2] Lauer GM(2001)Hepatitis C virus infection N Engl J Med 345 41-52

[3] Walker BD(1998)Determinants of outcome of compensated hepatitis C virus-related cirrhosis Hepatology 27 1435-40

[4] Serfaty L(2004)Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 S35-50

[5] Aumaitre H(1997)Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463-72

[6] Chazouilleres O(2013)Host factors determining the efficacy of hepatitis C treatment J Gastroenterol 48 22-30

[7] Fattovich G(2011)An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 1433-44

[8] Stroffolini T(2010)Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 1338-45

[9] Zagni I(2009)Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 1105-9

[10] Fattovich G(2009)IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 1100-4

[1] Hoofnagle JH(2002)Course and outcome of hepatitis C Hepatology 36 S21-9

[2] Lauer GM(2001)Hepatitis C virus infection N Engl J Med 345 41-52

[3] Walker BD(1998)Determinants of outcome of compensated hepatitis C virus-related cirrhosis Hepatology 27 1435-40

[4] Serfaty L(2004)Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 S35-50

[5] Aumaitre H(1997)Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463-72

[6] Chazouilleres O(2013)Host factors determining the efficacy of hepatitis C treatment J Gastroenterol 48 22-30

[7] Fattovich G(2011)An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 1433-44

[8] Stroffolini T(2010)Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 1338-45

[9] Zagni I(2009)Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 1105-9

[10] Fattovich G(2009)IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 1100-4